María Cruz Cruz Miraglia

Dr. María Cruz Cruz Miraglia


Research Focus & Metrics

Academic Career Length

9Years (2018-Present)

(Calculated once Scilit publication data is synced: current year − year of first publication + 1)

Representative Publications

View All Publications
15 August 2022 in Viruses
Verified
Journal Article
Open access
PDF file
SGSebastián Di Giacomo
Sebastián Di Giacomo
DBDanilo Bucafusco
Danilo Bucafusco
JSJuan Manuel Manuel Schammas
Juan Manuel Manuel Schammas
JPJuan Pega
Juan Pega
MMMaría Cruz Cruz Miraglia
María Cruz Cruz Miraglia
Daniel Mariano Pérez-FilgueiraDaniel Mariano Pérez-Filgueira
Daniel Mariano Pérez-Filgueira
Foot-and-mouth disease (FMD) remains one of the major threats to animal health worldwide. Its causative agent, the FMD virus (FMDV), affects cloven-hoofed animals, including farm animals and wildlife species, inflicting severe damage to the international trade and livestock industry. FMDV antigenic variability remains one of the biggest challenges for vaccine-based control strategies. The current study analyzed the host’s adaptive immune responses in cattle immunized with different vaccine protocols and investigated its associations with the clinical outcome after infection with a heterologous strain of FMDV. The results showed that antigenic payload, multivalency, and revaccination may impact on the clinical outcome after heterologous challenge with FMDV. Protection from the experimental infection was related to qualitative traits of the elicited antibodies, such as avidity, IgG isotype composition, and specificity diversity, modulating and reflecting the vaccine-induced maturation of the humoral response. The correlation analyses of the serum avidity obtained per vaccinated individual might suggest that conventional vaccination can induce high-affinity immunoglobulins against conserved epitopes even within different FMDV serotypes. Cross-reaction among strains by these high-affinity antibodies may support further protection against a heterologous infection with FMDV.

27 August 2020 in Pathogens
Verified
Journal Article
Open access
PDF file
ARAna Maria Rodriguez
Ana Maria Rodriguez
ATAldana Trotta
Aldana Trotta
AMAgustina Melnyczajko
Agustina Melnyczajko
MMMaría Cruz Cruz Miraglia
María Cruz Cruz Miraglia
KKKwang Sik Kim
Kwang Sik Kim
Guillermo GiambartolomeiGuillermo Giambartolomei
Guillermo Giambartolomei
Central nervous system invasion by bacteria of the genus Brucella results in an inflammatory disorder called neurobrucellosis. A common feature associated with this pathology is blood–brain barrier (BBB) activation. However, the underlying mechanisms involved with such BBB activation remain unknown. The aim of this work was to investigate the role of Brucella abortus-stimulated platelets on human brain microvascular endothelial cell (HBMEC) activation. Platelets enhanced HBMEC activation in response to B. abortus infection. Furthermore, supernatants from B. abortus-stimulated platelets also activated brain endothelial cells, inducing increased secretion of IL-6, IL-8, CCL-2 as well as ICAM-1 and CD40 upregulation on HBMEC compared with supernatants from unstimulated platelets. Outer membrane protein 19, a B. abortus lipoprotein, recapitulated B. abortus-mediated activation of HBMECs by platelets. In addition, supernatants from B. abortus-activated platelets promoted transendothelial migration of neutrophils and monocytes. Finally, using a pharmacological inhibitor, we demonstrated that the Erk1/2 pathway is involved in the endothelial activation induced by B. abortus-stimulated platelets and also in transendothelial migration of neutrophils. These results describe a mechanism whereby B. abortus-stimulated platelets induce endothelial cell activation, promoting neutrophils and monocytes to traverse the BBB probably contributing to the inflammatory pathology of neurobrucellosis.


4 November 2024 in Viruses
Verified
Journal Article
Open access
PDF file
MMMaría Cruz Cruz Miraglia
María Cruz Cruz Miraglia
MBMelanie Yazmin Barrios Benito
Melanie Yazmin Barrios Benito
SNSabrina Galdo Novo
Sabrina Galdo Novo
DBDanilo Bucafusco
Danilo Bucafusco
ATAna Inés Taffarel
Ana Inés Taffarel
Daniel Mariano Pérez-FilgueiraDaniel Mariano Pérez-Filgueira
Daniel Mariano Pérez-Filgueira
The high antigenic variability of the foot-and-mouth disease virus (FMDV) represents a challenge for developing prophylactic strategies, stressing the need for research into vaccines offering broad protection against a range of virus strains. Here, the heterotypic cross-reaction using different vaccine schemes against serotype O strains was studied, evaluating the impact of revaccination, antigen dose, and incorporation of additional FMDV serotypes. Naïve cattle were immunized with seven distinct FMDV vaccines, receiving three doses of the same formulation at 0, 28, and 56 days post-primary vaccination (dpv). Serum samples were collected up to 70 dpv and tested by a virus-neutralizing test against serotype O strains from a South American lineage and two strains representative of two Asian lineages. Our results showed that vaccines containing the ME-SA topotype O1/Campos strain developed cross-neutralizing responses against the two Asian viruses after the first vaccination. In contrast, significant heterotypic neutralizing antibody titers against the homologous topotype strain were only found after the second vaccination, indicating that the phylogenic relationship may differ from the antigenic profiles for these two viruses. The amount of the O1/Campos strain and the revaccination were essential factors for neutralization against the homologous- and heterologous-type O FMDV viruses. The strain composition of the vaccine was only relevant for cross-neutralization against one of the Asian strains, suggesting potential intra-serotypic divergences for this pattern.

28 December 2025 in Vaccines
Verified
Journal Article
Open access
PDF file
JSJuan Manuel Sala
Juan Manuel Sala
MWMaximiliano Wilda
Maximiliano Wilda
MMMaría Cruz Cruz Miraglia
María Cruz Cruz Miraglia
MCMariangeles Castillo
Mariangeles Castillo
Daniel Mariano Pérez-FilgueiraDaniel Mariano Pérez-Filgueira
Daniel Mariano Pérez-Filgueira
Alejandra Victoria CapozzoAlejandra Victoria Capozzo
Alejandra Victoria Capozzo
Background: Fasciola hepatica (F. hepatica) infection reduces antibody avidity to foot-and-mouth disease virus (FMDV) vaccination in cattle despite preserved total antibody levels. However, its effect on vaccine-induced immunity in water buffaloes (Bubalus bubalis), which contribute to FMDV maintenance in endemic settings, has not been investigated. Objectives: To evaluate the effect of natural F. hepatica infection on the magnitude and functional quality of the FMDV–specific antibody response in buffaloes under field conditions. Methods: Two buffalo herds (n = 50 each) were classified by infection status using coproparasitological analysis and serology. All animals were vaccinated within the national foot-and-mouth disease control programme, with the last dose administered 264 days before sampling. Serum neutralising titres, total antibodies by liquid-phase blocking ELISA, IgG levels, and IgG avidity to the A24/Cruzeiro vaccine strain were determined. Results: F. hepatica-infected buffaloes exhibited consistent decreases across all vaccine-induced antibody parameters. Neutralising titres were reduced approximately two-fold, IgG avidity by about 38 percent, IgG levels by about 36 percent, and liquid-phase blocking ELISA titres by about 1.6-fold compared with non-infected animals. Conclusions: This study provides the first field evidence that fasciolosis is associated with changes in the magnitude and quality of vaccine-induced humoral responses following FMDV vaccination in water buffaloes, indicating that F. hepatica infection may influence the interpretation of post-vaccination serological monitoring in this species under endemic field conditions.

30 September 2024 in Preprints.org
Verified
Preprint
Open access
PDF file
MMMaría Cruz Cruz Miraglia
María Cruz Cruz Miraglia
MBMelanie Yazmin Barrios Benito
Melanie Yazmin Barrios Benito
SNSabrina Galdo Novo
Sabrina Galdo Novo
DBDanilo Bucafusco
Danilo Bucafusco
ATAna Inés Taffarel
Ana Inés Taffarel
Daniel Mariano Pérez-FilgueiraDaniel Mariano Pérez-Filgueira
Daniel Mariano Pérez-Filgueira
The high antigenic variability of the foot-and-mouth disease virus (FMDV) represents a challenge for developing prophylactic strategies, stressing the need of research into vaccines offering broad protection against a range of virus strains. Here, the heterotypic cross-reaction using different vaccine schemes against serotype O strains was studied, evaluating the impact of revaccination, antigen dose, and incorporation of additional FMDV serotypes. Naïve cattle were immunized with seven distinct FMDV vaccines, receiving three doses of the same formulation at 0, 28 and 56 days post-primary vaccination (dpv). Serum samples were collected up to 70 dpv and tested by a virus-neutralizing test against serotype O strains from South American and two strains representative two Asian lineages. Our results showed that vaccines containing the ME-SA topotype O1/Campos strain developed cross-neutralizing responses against the two Asian viruses after the first vaccination. In contrast, significant heterotypic neutralizing antibody titers against the homologous topotype strain were only found after the second immunization, indicating that the phylogenic relationship may differ from the antigenic profiles for these two viruses. The amount of the O1/Campos strain and the revaccination were essential factors for neutralization against the homologous and heterologous type O FMDV viruses. The strain composition of the vaccine was only relevant for cross-neutralization against one of the Asian strains, suggesting potential intra-serotypic divergences for this pattern.